document.write("
"); document.write("
Vincenzi,\ M.*\ ; Kremić,\ A.*\ ; Jouve,\ A.*\ ; Lattanzi,\ R.*\ ; Miele,\ R.*\ ; Benharouga,\ M.*\ ; Alfaidy,\ N.*\ ; Migrenne-Li,\ S.*\ ; Kanthasamy,\ A.G.*\ ; Porcionatto,\ M.*\ ; Ferrara,\ N.*\ ; Tetko,\ I.V.\ ; Desaubry,\ L.*\ ; Nebigil,\ C.G.*
"); document.write("
Therapeutic potential of targeting prokineticin receptors in diseases.
"); document.write("
Pharmacol. Rev. 75, 1167-1199 (2023)
"); document.write("
"); document.write("
"); document.write("
Schumann,\ T.\ ; König,\ J.*\ ; Henke,\ C.\ ; Willmes,\ D.M.\ ; Bornstein,\ S.R.*\ ; Jordan,\ J.*\ ; Fromm,\ M.F.*\ ; Birkenfeld,\ A.L.
"); document.write("
Solute carrier transporters as potential targets for the treatment of metabolic disease.
"); document.write("
Pharmacol. Rev. 72, 343-379 (2020)
"); document.write("
"); document.write("
"); document.write("
Müller,\ T.D.\ ; Clemmensen,\ C.\ ; Finan,\ B.\ ; DiMarchi,\ R.D.*\ ; Tschöp,\ M.H.
"); document.write("
Anti-obesity therapy: From rainbow pills to polyagonists.
"); document.write("
Pharmacol. Rev. 70, 712-746 (2018)
"); document.write("
"); document.write("
"); document.write("
Korkmaz,\ B.*\ ; Lesner,\ A.*\ ; Guarino,\ C.*\ ; Wysocka,\ M.*\ ; Kellenberger,\ C.*\ ; Watier,\ H.*\ ; Specks,\ U.*\ ; Gauthier,\ F.*\ ; Jenne,\ D.
"); document.write("
Inhibitors and antibody fragments as potential anti-inflammatory therapeutics targeting neutrophil proteinase 3 in human disease.
"); document.write("
Pharmacol. Rev. 68, 603-630 (2016)
"); document.write("
");